Two particulate structures based on AHSV major structural protein VP7, are under investigation as possible vectors for epitope display. Due to the extreme insolubility of the VP7 protein it aggregates into large hexagonal crystalline particles when expressed in an insect cell expression system (Chuma et aI, 1992). To investigate its ability to present immunologically important epitopes to the immune system, VP7 mutants have been constructed that allow the presentation of foreign peptides on the surface these particles (Maree, 2000). In part of this study AHSV core-like particles resulting from the co-expression of the two major structural proteins VP3 and VP7 were under investigation. Due to the low solubility of VP7, low core-like particle yields are obtained during co-expression (Maree, 2000). As a result not enough of the particles can be produced to make its use viable. To increase the core-like particle yield it is necessary to increase the solubility of VP7. Several amino acids have been implicated in the observed low solubility of VP7 (Monastyrskaya et aI, 1997). One of these amino acids was targeted for site-specific mutation in an effort to increase protein solubility. Leucine 345 is located on the ninth C-terminal helix in the bottom domain of VP7 and was substituted to arginine, a polar positively charged residue. The substitution was made in wild type VP7 as well as in insertion mutants 177 and 200. The mutation was effected via PCR and the resulting mutant genes were expressed in the Bac-To-Bac expression system. The newly constructed mutant proteins were further investigated for an increase in solubility by differential and sucrose density centrifugation. The site specific mutation in wild type VP7 and insertion mutant 200 resulted in a slight increase in solubility whereas the mutation in mutant 177 had no effect on solubility. As a result of failing to significantly increase the solubility of these mutants, no increase in the core-like particle yield was achieved. In the second part of this study recombinant VP7 crystals were constructed which present a single and triple repeat of the HIV-1 transmembrane protein gp41 neutralizing antibody epitope, ELDKWA. To this end, oligonucleic acid adaptors coding for the epitope repeats were designed and cloned into VP7 insertion sites 144 and 177. The newly constructed VP7 mutant genes were expressed in the Bac-to-Bac expression system and the recombinant proteins were investigated for its solubility and crystal formation by sucrose density gradient centrifugation. All of the epitope presenting constructs were significantly less soluble than insertion mutants 144 and 177 and retained its ability to assemble into large hexagonal crystals. Gradient purified particles were injected into Balb/c mice and the epitope specific antibody response determined by dot and western blot analysis. Although a humoral immune response was induced against the VP7 constructs none were able to induce antibody responses specific to the ELDKWA epitope. / Dissertation (MSc (Genetics))--University of Pretoria, 2005. / Genetics / unrestricted

Factors that determine the molecular basis of African horsesickness virus (AHSV) virulence are unclear. Several proteins and different events in the viral replication cycle together with different environmental factors are likely to contribute to the virulence phenotype. The aim of this investigation was to study the possible contribution of AHSV nonstructural protein NS3 to virus virulence. NS3 is a cytotoxic protein that localizes in areas of plasma membrane disruption and is assumed to be associated with the release of virus particles from infected cells. A conserved feature in all AHSV NS3 proteins is the presence of two hydrophobic domains. To investigate whether these hydrophobic domains interact with membranes, cell surface localization and membrane association studies were conducted on NS3 and the two hydrophobic domain mutant forms of NS3. Results indicated that mutations in either hydrophobic domain did not prevent membrane targeting but abolished membrane anchoring. This prevented cell surface localization and obviated the cytotoxic effect of NS3. AHSV NS3 is a highly variable protein. This level of variation may influence virulence properties. To compare the NS3 sequence variation level of South African AHSVs and bluetongue viruses (BTV/s) with those previously described, the NS3 protein sequences of field isolates, reference and vaccine strains were determined and analysed. The variation level of AHSV NS3 was found to be higher than previously reported. Comparison of the AHSV vaccine and field strain NS3 sequences revealed no obvious NS3 virulence marker. The level of AHSV NS3 sequence variation could distinguish between field isolates and vaccine strains and differentiate between sub-populations within a serotype. The inferred phylogeny of AHSV NS3 corresponded well with the described NS3 phylogenetic clusters with exception of AHSV-8 and one AHSV-6 encoded NS3. BTV NS3 inferred phylogeny indicated that the three BTV NS3 clusters that occur as geographically defined entities are all simultaneously present in S.A. This would suggest that BTV originated in southern Africa. To investigate the impact of minor NS3 variation on AHSV virulence, the membrane permeabilization properties of AHSV-2 vaccine and virulent NS3 proteins were compared. The AHSV-2 S10 genes were cloned and NS3 was expressed using the BAC-TO-BAC system. The membrane permeabilization effect of NS3 expression was monitored by calcium influx into insect cells. Expression of either the vaccine or virulent associated AHSV-2 NS3 protein equally increased membrane permeability. The NS3 sequence variation therefore had a limited influence on membrane permeabilization properties and the virulence status of the vaccine and virulent AHSV-2 strains in this study. The possible effect of larger NS3 sequence variation levels on AHSV virulence was investigated by NS3 associated properties such as virus release and membrane permeabilization. AHSV infections increased the permeability of cell membranes and the different strains had different virus release properties. Virus release was not exclusively related to increased membrane permeability of infected cells or to the yield of the virus in the infected cells. The level of NS3 variation may influence AHSV release mechanisms and membrane permeabilization properties thereby contributing to AHSV virulence properties. / Thesis (PhD (Genetics))--University of Pretoria, 2005. / Genetics / unrestricted

Thesis (MSc (Veterinary Science))--University of Pretoria, 2002. / Includes bibliographical references.

African horsesickness virus (AHSV), a member of the Orbivirus genus in the family Reoviridae, is the aetological agent of an economically important disease affecting equids. One of the outer coat proteins of the virus, VP5, has the important function of interacting with the conserved core proteins as well as adapting to facilitate changes in the major outer coat protein, VP2. VP5 plays a role in destabilizing the endosomal membrane following viral attachment to the host cell, thereby allowing access of the viral core into the host cytoplasm. Furthermore, VP5 contributes to the immune response in infected animals and has relevance to recombinant vaccine development. The main aim of this study was to compare the genetic variation between VP5 proteins of field isolates of AHSV, isolated from dead animals, to that of laboratory strains, likely to be avirulent. This comparison was done in order to determine if any significant/common amino acid changes could be linked to the virulence phenotype. The VP5 genes of six AHSV isolates of serotypes 3, 6, 8 and 9 respectively were cloned, sequenced and the amino acid sequences deduced. This study represents the first report on the sequencing analysis of the VP5 gene and protein of an AHSV serotype 8. All sequences were aligned and compared to those of published laboratory/vaccine strains, and other available sequence data. Interserotype amino acid identities of between 95% and 99% were observed between isolates of serotypes 3, 6 and 9 (apart from a laboratory strain of AHSV9), indicating significant conservation between these serotypes. The VP5 protein of AHSV8 showed less homology and differed from the other serotypes by between 5.2 and 7%. The AHSV4 protein differed significantly from the rest, showing between 15 and 19% amino acid differences. The identity between the VP5 proteins of different isolates/strains of the same serotype was very high in most instances, at approximately 97% for different AHSV3 strains and 94 % for different AHSV6 strains. The VP5 protein of a laboratory adapted strain of AHSV9, however, differed from an AHSV9 field isolate by nearly 10%. In the analyses of these amino acid differences, no common amino acid change, indicative of a virulence marker, could be identified between the assumedly virulent field isolates and their respective laboratory adapted strains. Furthermore, no distinctive differences in regions supposedly involved in membrane destabilization, or particular patterns of variation were observed. The results indicate that virulence of a particular AHSV serotype is unlikely to be influenced by a common amino acid change in VP5, and more likely to be multi-faceted. The second aim of this study was to investigate whether VP5 has a cytotoxic effect when expressed in a bacterial system, in light of similar effects reported for the analogous protein of bluetonguevirus (BTV), a related orbivirus. Computer analyses were performed and indicated that amphipatic helices found in the N-terminus of BTV VP5, proposed to be responsible for cytotoxicity, were also present in AHSV VP5. A full-length copy of the AHSV4 VP5 gene was cloned into the pET41 transfer plasmid and expression induced in bacterial cells. Optical density measurements of the bacterial cultures, indicative of cell growth, were taken at time intervals post induction. The expression of AHSV VP5 clearly had a severe negative effect on cell density (hence growth) over time, in contrast to a control where the cell density continued to increase. The results therefore clearly indicated that expression of AHSV VPS was cytotoxic to bacterial cells. Lastly, a neutralizing epitope present on VPS was expressed on the surface of a particulate display system, based on crystalline particles formed when the VP7 protein of AHSV9 is expressed in insect cells. Expression of the VP7/epitope A chimeric protein was confirmed by polyacrylamide gel electrophoresis and partially purified by sucrose gradient separation. Hexagonal crystals with a unique surface structure, but morphologically quite similar to VP7 crystals, were observed by scanning electron microscopy. The VP7 display vector could therefore tolerate insertion of the epitope without losing its ability to form crystals. The chimeric particles are now available for further evaluation as to its immunological properties. The results of this study should contribute to the development of a possible vaccine strategy against AHS in future. / Dissertation (MSc (Genetics))--University of Pretoria, 2007. / Genetics / unrestricted

African horse sickness (AHS) is a life threatening disease of equids caused by African horse sickness virus (AHSV), a member of the genus Orbivirus in the family Reoviridae. The virus is transmitted to horses by midges (Culicoides spp.) and the disease is most prevalent during the time of year, and in areas where the Culicoides spp. are most abundant, namely in late summer in the summer rainfall areas of the country. Whilst the clinical signs and presentation of the disease were well documented by Sir Arnold Theiler (1921), very little is known or documented about AHSV dynamics or the clinical pathological and serological responses of horses to natural infection with AHSV. This dissertation describes the history and current knowledge on AHS, and the methods and results of a prospective study on natural AHSV infection of horses, undertaken between 2009 and 2010 by the Equine Research Centre (ERC) at the University of Pretoria, Faculty of Veterinary Science, Onderstepoort. This study is the first documented study of its nature and included animals of various ages and therefore variable vaccination status. The objectives of the study were to describe the viral dynamics of AHSV infection in horses, to gain a better understanding of the clinical pathological and serological responses to natural AHS infection and to demonstrate early detection of AHS infection in horses under field conditions. / Dissertation (MSc)--University of Pretoria, 2010. / Veterinary Tropical Diseases / unrestricted

African horsesickness is an infectious but non-contagious disease caused by an orbivirus belonging to the Reoviridae family. The disease is classified as notifiable by the OlE because of the potential severe economic consequences that can result from outbreaks. Bluetongue, an arthropod-transmitted disease of wild and domestic ruminants, is caused by the bluetongue virus, which is the prototype species of the genus Orbivirus. Bluetongue is also a notifiable disease because it can spread very rapidly in naive populations of susceptible livestock. Strict restrictions have been issued for the trade in animals and animal products from infected areas. In the present study, a duplex one-step real-time RT-PCR using the fluorogenic dye SYBR® Green I was developed for the specific detection and identification of AHSV and BTV in one reaction, using melting temperatures (Tm) to discriminate between the viruses. Two primers pairs were designed to bind to areas of homology within genome segment 7 (VP7) of AHSV and genome segment 5 (NS1) of BTV respectively. The duplex real-time RT -PCR based test utilizes single tube RT -PCR amplification in which AHSV and BTV primers were used simultaneously. The RT-PCR primers amplified 232 bp of genome segment 7 from all nine serotypes of AHSV and 79 bp of genome segment 5 from all 22 BTV serotypes that were tested. When both viruses were present, two melting peaks were simultaneously generated at 76.30°C and 80.04°C representative of BTV and AHSV amplification products respectively. Serogroup-specific products were amplified from dsRNA of field isolates of AHSV and BTV. dsRNA from EHDV and EEV failed to demonstrate either the 232 bp specific AHSV PCR product or the 79 bp specific BTV product. These results indicate that the duplex real-time RT-PCR could be a useful technique for detection of AHSV and BTV from isolated viral dsRNA. / Dissertation (MSc)--University of Pretoria, 2008. / Veterinary Tropical Diseases / unrestricted

African horse sickness virus (AHSV) is a ten-segmented, dsRNA virus, classified as a distinct species within the genus Orbivirus, family Reoviridae. There are nine serotypes of AHSV, any of which can cause African horse sickness (AHS), an extremely severe ‘transboundary’ and notifiable disease of horses, listed by OIE. AHS is currently restricted to sub-Saharan Africa, but has occasionally emerged causing major outbreaks in other geographic regions. Complete genome nucleotide sequences were determined for nine reference-strains of AHSV (different serotypes). The selection-pressure on each genome-segment and its encoded proteins, in relation to protein function were analysed in phylogenetic comparisons. This initial AHSV sequence database also provided a basis for molecular-epidemiology studies. In particular, the role of the Seg-2 in determination of virus-serotype was used to identify viruses involved in a multi-serotype outbreak, identifying Ethiopia as an important area of AHSV circulation. Phylogenetic-relationships were also investigated between different isolates of AHSV serotypes 2, 4, 6, 8 and 9, from various locations in Africa. Two real-time RT-PCR assays were developed for detection of the highly conserved genome segments 1 and 3, and molecular diagnosis of AHSV. Real-time RT-PCR assays were also developed, targeting Seg-2, for detection and identification of the nine AHSV serotypes. These assays are suitable for ‘high throughput’ characterisation of AHSV outbreak-strains, from either endemic or AHSV-free zones. The results obtained would facilitate rapid design and implementation of appropriate virus control measures. Cross-contamination was detected in four of the original AHSV reference-strains. A new set of plaque-cloned and monotypic reference-strains was therefore identified and characterised, and is available through the Orbivirus Reference Collection (http://www.reoviridae.org/dsRNA_virus_proteins/ReoID/AHSV-Nos.htm). Serological relationships were analysed using antibodies against VP2 of AHSV-9 (expressed by recombinant MVA) and the nine monotypic reference-strains, showing neutralisation of both AHSV-9 and AHSV-6, in agreement with their closer phylogenetic relationship within Seg-2/VP2.

African horse sickness (AHS) was reported in the south-western Khomas Region, central Namibia (22° 24.063´ S, 17° 01.791´ E; 23° 32.617´ S, 15° 53.870´ E), contrary to expectations that the arid conditions in the area would limit its occurrence. This prompted investigation into the occurrence of AHS in horses, a possible reservoir animal, the Hartmann’s mountain zebra (Equus zebra. hartmannae) and the occurrence of the Culicoides midge vector (Diptera: Ceratopogonidae) of the disease in the area. Questionnaires were used to explore the geographic characteristics of the study area, the occurrence of an expected AHS virus reservoir animal, E. z. hartmannae and AHS in horses in the study area. According to the questionnaire, rainfall patterns seem to follow topography of the area, where the north-east formed the higher rainfall (420 mm/a) high-ground and the south-western formed the lower rainfall (120 mm/a) pediment zone in the south-west. Cases of AHS occurred mostly in mid-rainfall zones. E. z. hartmannae were present throughout the area. They migrated from the southwest towards the north-eastern high-grounds during droughts, presumably along ephemeral river beds. E. z. hartmannae were sampled for blood and tissues and analysed for evidence of African Horse Sickness Virus (AHSV) infection by indirect ELISA, RT-PCR and virus isolation techniques. All useable samples tested positive for anti-AHSV antibodies. Viral RNA was demonstrated in 26% of all the zebra sampled. No viable viruses were isolated from these samples, however further research is required, as difficult sampling conditions may have yielded false-negatives. From 6 July to 21 September 2009, Culicoides midges were collected during the dry winter season in suction UV-light traps installed at five selected sites along a rainfall gradient. In 38 collections, a total of 9091 Culicoides individuals, representing 25 species were collected. The dominance of the proven vector of AHSV, Culicoides imicola Kieffer, varied in dominance from 94% near Windhoek with high altitude and relatively higher annual rainfall, to 12% at the site situated farthest southwest, with the lowest altitude and annual rainfall. From what was observed of the occurrence of AHS in horses, E. z. hartmannae and the distribution and abundance of the AHSV vector (Culicoides spp.), it was concluded that AHS can be maintained in the south-western Khomas Region even in the lowest mean annual rainfall zones. / Thesis (MSc (Environmental Sciences))--North-West University, Potchefstroom Campus, 2012

African horse sickness (AHS) was reported in the south-western Khomas Region, central Namibia (22° 24.063´ S, 17° 01.791´ E; 23° 32.617´ S, 15° 53.870´ E), contrary to expectations that the arid conditions in the area would limit its occurrence. This prompted investigation into the occurrence of AHS in horses, a possible reservoir animal, the Hartmann’s mountain zebra (Equus zebra. hartmannae) and the occurrence of the Culicoides midge vector (Diptera: Ceratopogonidae) of the disease in the area. Questionnaires were used to explore the geographic characteristics of the study area, the occurrence of an expected AHS virus reservoir animal, E. z. hartmannae and AHS in horses in the study area. According to the questionnaire, rainfall patterns seem to follow topography of the area, where the north-east formed the higher rainfall (420 mm/a) high-ground and the south-western formed the lower rainfall (120 mm/a) pediment zone in the south-west. Cases of AHS occurred mostly in mid-rainfall zones. E. z. hartmannae were present throughout the area. They migrated from the southwest towards the north-eastern high-grounds during droughts, presumably along ephemeral river beds. E. z. hartmannae were sampled for blood and tissues and analysed for evidence of African Horse Sickness Virus (AHSV) infection by indirect ELISA, RT-PCR and virus isolation techniques. All useable samples tested positive for anti-AHSV antibodies. Viral RNA was demonstrated in 26% of all the zebra sampled. No viable viruses were isolated from these samples, however further research is required, as difficult sampling conditions may have yielded false-negatives. From 6 July to 21 September 2009, Culicoides midges were collected during the dry winter season in suction UV-light traps installed at five selected sites along a rainfall gradient. In 38 collections, a total of 9091 Culicoides individuals, representing 25 species were collected. The dominance of the proven vector of AHSV, Culicoides imicola Kieffer, varied in dominance from 94% near Windhoek with high altitude and relatively higher annual rainfall, to 12% at the site situated farthest southwest, with the lowest altitude and annual rainfall. From what was observed of the occurrence of AHS in horses, E. z. hartmannae and the distribution and abundance of the AHSV vector (Culicoides spp.), it was concluded that AHS can be maintained in the south-western Khomas Region even in the lowest mean annual rainfall zones. / Thesis (MSc (Environmental Sciences))--North-West University, Potchefstroom Campus, 2012

African horse sickness virus (AHSV) affects equine populations around the world. It is the cause of a high rate of morbidity and associated large economic losses in affected regions. The virus is a segmented double stranded RNA virus and a member of Orbivirus genus in the Reoviridae family. The prototype member of the orbiviruses is bluetongue virus (STY) and other members include Chuzan virus and St. Croix River virus. These viruses are all characterized by a genome of ten dsRNA segments that encode at least ten different proteins. Three of the minor core proteins are found within the core of BTV. These are all associated with the RNA transcription complex and the enzymatic activities with which they are associated include an RNA polymerase (VP1), an RNA capping enzyme (VP4) and an RNA helicase (VP6). Genes homologous to the BTV genes that encode these proteins are found in all members of the Orbivirus genus. The aim of this thesis is to characterize VP4 of AHSV, the capping enzyme candidate, and to compare it to other orbivirus capping enzymes. Possible functional motifs and regions of importance within the orbivirus capping enzymes will be identified. The gene will also be expressed and used to perform assays to characterize the different enzymatic activities of VP4. The VP4 cDNA of AHSV serotype 3 was cloned and sequenced. From the full-length verified nucleotide sequence an open reading frame was identified and used to predict the amino acid sequence. These were compared to other orbivirus species including STY, Chuzan virus and St. Croix River virus. These alignments identified a number of highly conserved regions, consisting of four or more amino acids conserved between all the sequences analyzed. A fibronectin type 3-like motif, containing 12 conserved amino acids, was identified which could be responsible for protein binding. This motif contains 12 conserved amino acids making it a good candidate for a functional motif. Conservation does not, however, always predict regions of importance. In BTV a lysine-containing motif was identified to be responsible for GMP binding. This region is not conserved between the different viruses. AHSV has a motif containing a lysine residue similar to the motif identified in rotavirus and reovirus. Two other motifs described in BTV were also not conserved in the other viruses. One of them, a leucine zipper, was shown to dimerize BTV VP4. Phylogenetically, AHSV and Chuzan virus are the most closely related while BTV is more distant and St. Croix River virus forms a distinct out-group when the different VP4 sequences are compared. AHSV-3 VP4 was expressed as a histidine-tagged protein in the baculovirus expression system. Not unexpectedly, the protein was found to be insoluble, similar to BTV VP4 produced by means of the same system. However, whereas BTV VP4 could be solubilized by the addition of salt the AHSV VP4 remained insoluble at high salt concentrations. Several adjustments were made. Cells were lysed in a high salt buffer, the pH of the buffers was adjusted and sucrose cushions were used but none of the methods was found to improve the yield of soluble VP4 significantly. However, the pellet containing VP4 was relatively empty of contaminating protein and, therefore, a number of enzymatic assays were performed with the pellet. Assays for inorganic phosphatase and nucleotide phosphatase were performed. Strikingly, both assays indicated the presence of active phosphatases in the WT and VP4 pellets. Also, an assay was performed for guanylyltransferase activity but no activity was observed for this assay. The sequence data therefore points to VP4 as the probable capping enzyme although it may have a different structural complex. The failure to produce a reliable source of soluble purified AHSV VP4 made it impossible to provide evidence to confirm the associated enzymatic activities. / Dissertation (MSc(Genetics))--University of Pretoria, 2005. / Genetics / unrestricted